Observational study / 2015
Elevated TMAO levels were associated with heart failure severity and reduced transplant-free survival.
A prospective observational study examined plasma levels of trimethylamine-N-oxide (TMAO), choline, and betaine in 155 chronic heart failure (HF) patients, 100 stable CAD patients, and 33 healthy controls. TMAO (P = 0.01), choline (P < 0.001), and betaine (P < 0.001) were elevated in HF patients compared with controls, with highest levels in NYHA classes III and IV. TMAO, but not choline or betaine, was linked to reduced transplant-free survival, with approximately 50% of HF patients in the upper tertile dying or receiving a heart transplant during 5.2 years of follow-up (unadjusted HR 2.24, 95% CI 1.28-3.92, P = 0.005).
Shows an association, not proof of cause and effect.
- Study type
- Prospective observational study
- Who was studied
- 155 patients with chronic heart failure, 100 with stable CAD without HF, and 33 healthy controls
- What was measured
- Symptoms, aetiology, and transplant-free survival over 5.2 years of follow-up
THE PAPER
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A. J Intern Med, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.